SV

Street Verdict

Analyst Scorecard

A record of what Sachin Shah said publicly, with the source. Not advice.

Pending — not yet graded
“Bullish on the Pharma sector, specifically the CDMO and CRAMS segments, where they hold a decent allocation. They believe this business area should perform quite well, positioning them for decent returns.”
Nifty PharmaBullishCalled 05 Feb 2025
Verdict:PENDING

This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.

Read the original articleSee Sachin Shah’s full track record